Bracken

When launching a product or service, it all comes down to one essential question: what problem are you really trying to solve?? ? In this SNiP, global marketing strategist and life science industry expert Mary Costello breaks down the essential steps to uncovering the root causes of a company’s marketing challenges. From the importance of understanding buyer behavior to the consequences of burning through time and money without validating demand, Mary shares the realities of marketing that every life science startup, large-scale company, and clinical research organization must face.? ? With practical advice on avoiding costly mistakes and insight into aligning your strategy with customer needs, Mary’s approach is as actionable as it is insightful—and she delivers it in under 8 minutes.?? ? Tune in now, and subscribe to Fractals to be the first to hear Mary’s upcoming full-length episode: https://lnkd.in/e8W7ckqp ? #FractalsSNiPs #FractalsLifeScienceConversations #MarketingStrategy #LifeSciences #ClinicalResearch #BusinessDevelopment #LifeSci?

Our newsletter, The Leaflet, is your monthly dose of concise, curated insights for busy life science professionals. In our fast-paced pharma world, we deliver high-quality information without the clutter. Subscribe today: https://hubs.la/Q02YvdZr0 #Pharma #Newsletter

In the next quarter, the FDA is gearing up to make some key decisions on five drugs. One of particular interest is BridgeBio Pharma's acoramidis in transthyretin amyloidosis cardiomyopathy. This drug rebounded from lackluster Phase 3 trial results, which is highly unusual in the industry. New drugs from AstraZeneca and Daiichi Sankyo, Vertex, PTC Therapeutics, and Bristol Myers Squibb all feature in this list too: https://hubs.la/Q02W6M6x0 #FDA #DrugDev

Even drugs with “blockbuster potential” can fall short of expectations. If you want to avoid having a flop on your hands, this article explains what to do (and not to do) to help a new medication pass the $1 billion mark: https://hubs.la/Q02W6Q4F0 #Pharma #DrugDev

What’s the secret to standing out in the crowded and competitive life sciences marketplace? It starts with mastering the fundamentals—then thinking outside the box. Whether you're in biotech, pharma, or healthcare, these 5 options will inspire fresh approaches to your marketing strategy, helping you captivate your audience and drive results: https://lnkd.in/d8uk6mnV #LifeSci #MarketingStrategy #DataAnalytics #Advertising #DigitalMarketing #Bracken

Jim Gilligan, MSIB, PhD, Managing Partner at Bracken has a wealth of biotech/biopharma leadership, drug development, and strategic planning experience. Here's what he has to say about starting out in the industry and bringing a concept to fruition as a registered commercial product, "As you get into this industry, you realize there's a lot more that goes into it than just doing experiments. You get into clinical, regulatory, CMC, and so on. The journey may have started with doing research, but then you need to understand what it really takes to bring that concept to fruition as a registered commercial product." #Biotech #Commercialization

What’s the missing ingredient in your AI strategy? AI thrives on data—but without human expertise, it can miss the mark. Life science professionals can harness the power of domain insights to teach AI systems smarter, more impactful lessons. Learn how in this blog, written by Bracken Senior Partner Paul Martinetti, MD: https://lnkd.in/eWM_zfqK #RichLearningExperience #AI #Data #ExperInsights #AITraining #LifeSci #Bracken

In the biopharmaceutical industry, groundbreaking discoveries may start in the lab—but to reach the market, they require more than just great science. In this?SNiP, life sciences veteran?Dr. Graham Lumsden?highlights an essential yet often overlooked step: identifying unmet medical needs before developing a solution. Drawing from decades of experience, Graham shares the value and necessity of a market-first approach, where science and business strategy align to drive commercial success. Especially relevant for researchers and investors seeking to bridge the gap between discovery and market adoption, Graham discusses the importance of anticipating customer needs and ensuring a clear path to profitability—a critical foundation that turns innovative research into impactful, sustainable products. Tune in for Graham’s practical approach and subscribe to Fractals on your favorite podcast platform to be the first to hear the full conversation: https://lnkd.in/eMXRtej8 #SNiPsFractalsLifeScienceConversations #FractalsLifeScienceConversations #ProductDevelopment #MarketAnalysis #Commercialization #Investment #LifeSci #Bracken

Biotech appears to be entering its optimistic era driven by a spike in biotech mergers, acquisitions and IPOs—collectively referred to as “exits”. Find out what industry experts have to say about these latest developments: https://hubs.la/Q02W6CYP0 #Biotech #IPOs

The Boston Imaging Round Table is tomorrow—Bracken CEO and medical imaging expert Colin Miller, PhD, FIPEM, CSci, will be in attendance. Meet Colin and learn more about Bracken’s wider imaging team here: https://lnkd.in/eNYhT_ft #MedicalImaging #ClinicalTrials #Imaging #LifeSci #Bracken